细胞内巴克利泰克素纳米颗粒形成增强了微管聚合和PANoptosis的细胞内增强
Xiaoyang Liu1, Xianbao Sun1, Yu Ma1
1State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, 2 Southeast University Road, Nanjing, 211189, China.
Angewandte Chemie (International ed. in English)
|December 24, 2025
概括
这项研究引入了一种新型的帕克利塔塞尔结合物,该结合物在癌细胞内形成纳米颗粒,放大亡并改善抗癌效应. 这种创新方法通过创建放大循环来改善瘤治疗,从而提高治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 帕克利塔克塞尔的临床使用受到剂量限制性毒性和低效的细胞输送的阻碍.
- 现有的纳米配方在实现有效的细胞内药物度方面面临挑战.
- 提高细胞内帕克利塔克塞尔纳米结构的抗癌疗效需要新的策略.
研究的目的:
- 开发一种帕克利塔塞尔结合物,可以在细胞内形成纳米颗粒,从而放大亡,从而增强抗癌效果.
- 设计一个利用caspase-3活动为自我放大纳米粒子形成循环的系统.
- 调查这种策略在改善瘤治疗方面的潜力.
主要方法:
- 合成一个对卡斯帕-3反应性-帕克利塔塞尔合物 (Ac-DEVDC(StBu) K(PTX) -CBT).
- 通过降低谷氨和caspase-3裂变触发的细胞内纳米粒子形成的研究.
- 对体外抗癌活性的评估,包括细胞循环抑制和PANoptosis的诱导.
- 在体内疗效的评估在 ортотоп瘤模型中,测量caspase-3水平和生存率.
主要成果:
- 结合物在细胞内自组装成帕克利塔塞尔纳米粒子,形成一个放大循环.
- 试验室研究显示显著的细胞循环抑制,减少酸化YAP-1,并诱导了PANoptosis.
- 在体内研究表明,与自由帕克利塔塞尔相比,卡斯帕-3的表达增加和延长存活时间.
- 该机制涉及细胞骨破坏和亡放大.
结论:
- 开发的帕克利塔塞尔结合物有效地形成细胞内纳米粒子,放大细胞亡并增强治疗结果.
- 这一策略提供了一种有希望的方法来克服帕克利塔克塞尔的局限性,以改善癌症治疗.
- 自放大纳米粒子形成循环为提高抗癌疗效提供了一种新的机制.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
19.1K
08:29Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
10.5K
相关概念视频
01:15Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
01:31The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
01:18Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
01:17The Extrinsic Apoptotic Pathway
8.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
01:30Apoptosis
13.9K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
13.9K
01:10Drugs that Destabilize Microtubules
3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K